Snss stock zacks
The latest closing stock price for Sunesis Pharmaceuticals as of December 31, 2019 is 0.34. The all-time high Sunesis the last 52 weeks is 0.76. Compare SNSS With Other Stocks.. Fundamental data from Zacks Investment Research, Inc. Check out our BMRN stock analysis, current BMRN quote, charts, and historical prices for Biomarin Pharmaceuticals By Zacks Investment Research Jun 15, 2018 5 Great Biotech Stocks to Buy Now (CLLS, CELG, EXAS, EXEL, SNSS). Sunesis Pharmaceuticals Inc information page, at Preferred Stock ChannelSunesis Pharmaceuticals Inc, 6 days ago The stock had previously closed at $0.32. A number of research firms have weighed in on SNSS. Zacks Investment Research raised Sunesis 4 Jul 2019 Let's take a look into the factors that are driving this Zacks Rank #2 (Buy) stock. What's Going in APD's Favor? Upbeat outlook and healthy
Check out our EXAS stock analysis, current EXAS quote, charts, and historical prices for Exact Sciences Cor stock
11/4/2019 · Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.09. The reported EPS for the same quarter last year was $-0.18. 8/18/2016 · SUNESIS PHARMA (SNSS): Free Stock Analysis Report. ANI PHARMACEUT (ANIP): Free Stock Analysis Report. To read this article on Zacks.com click here. Zacks Investment Research. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Stock quote for Sunesis Pharmaceuticals, Inc. Common Stock Common Stock (SNSS) with real-time last sale and extended hours stock prices, company news, charts, and SNSS Forecast and Technical Stock Analysis Hold candidate since 2019-12-26 Gain 1.47% PDF Sunesis Pharmaceuticals gained 1.47% in the last trading day ( Friday, 27th Dec 2019 ), rising from $0.35 to $0.35 , and has now gained 4 days in a row. Real-time trade and investing ideas on Sunesis Pharmaceuticals Inc. SNSS from the largest community of traders and investors.
Sunesis Pharmaceuticals Stock Price, Chart, Latest News, Technical Indicator and other information
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Options Traders Expect Huge Moves in Sunesis (SNSS) Stock. by Zacks Equity Research Published on June 17,2019 . Investors need to pay close attention to Sunesis (SNSS) stock based on the movements in the options market lately. SNSS. medical Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Revenue (TTM) is a widely used stock evaluation measure. Find the latest Revenue (TTM) for Sunesis Pharmaceuticals, Inc. (SNSS) Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. 4/9/2018 · Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Sunesis Pharmaceuticals, Inc. (SNSS): Free Stock Analysis Report. To read this article on Zacks.com click here. Zacks Investment Research
Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group. TheStreet Ratings updates stock ratings daily.
Revenue (TTM) is a widely used stock evaluation measure. Find the latest Revenue (TTM) for Sunesis Pharmaceuticals, Inc. (SNSS) Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. 4/9/2018 · Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Sunesis Pharmaceuticals, Inc. (SNSS): Free Stock Analysis Report. To read this article on Zacks.com click here. Zacks Investment Research
6/23/2015 · Sunesis Pharmaceuticals, Inc. ( SNSS ) was a big mover last session with its shares rising just over 9% on the day. The move came on solid volume. Sunesis (SNSS) Worth Watching: Stock Moves 9.1% Higher - Tale of the Tape | Nasdaq
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Options Traders Expect Huge Moves in Sunesis (SNSS) Stock. by Zacks Equity Research Published on June 17,2019 . Investors need to pay close attention to Sunesis (SNSS) stock based on the movements in the options market lately. SNSS. medical
Sunesis Pharmaceuticals Inc information page, at Preferred Stock ChannelSunesis Pharmaceuticals Inc,